Plasma and abscess fluid pharmacokinetics of cefpirome and moxifloxacin after single dose and multiple dose administration - Abscess-Cef-Moxi
- Conditions
- Abscess or abdominal cyst
- Registration Number
- EUCTR2005-004455-35-AT
- Lead Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
•Female or male, aged between 18 and 90 years.
Written informed consent.
Abscess formation or abdominal cyst scheduled to drainage.
Plasma creatinine <1.5 mg/dL
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
•Pregnancy or lactation.
•Hemodialysis or hemofiltration
•Allergy or hypersensitivity against study drugs
•Massive edemata or hypernatremia
•Reduced liver function (Child-Pugh A, B, C)
•Relevant prolongation of QT-interval
•CNS-diseases which predispose for cramps
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method